Bio-Connect
WB analysis of rat kidney (lanes 1 and 3) and brain (lanes 2 and 4) membrane lysates using GTX16644 KIR2.3 antibody preincubated with or without immunogen peptide. Dilution : 1:200
WB analysis of rat kidney (lanes 1 and 3) and brain (lanes 2 and 4) membrane lysates using GTX16644 KIR2.3 antibody preincubated with or without immunogen peptide. Dilution : 1:200
WB analysis of rat kidney (lanes 1 and 3) and brain (lanes 2 and 4) membrane lysates using GTX16644 KIR2.3 antibody preincubated with or without immunogen peptide. Dilution : 1:200

KIR2.3 antibody

GTX16644
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetKcnj4
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    KIR2.3 antibody
  • Delivery Days Customer
    7
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.8 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID116649
  • Target name
    Kcnj4
  • Target description
    potassium inwardly-rectifying channel, subfamily J, member 4
  • Target synonyms
    BIR11; brain inwardly rectifying K(+) channel 2; Hirk2; inward rectifier K(+) channel Kir2.3; inward rectifier potassium channel 4; IRK3; IRK-3; potassium channel, inwardly rectifying subfamily J member 4; potassium voltage-gated channel subfamily J member 4
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP52190
  • Protein Name
    Inward rectifier potassium channel 4
  • Scientific Description
    inwardly-rectifying potassium channel [RGD, Feb 2006]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Activation of Kir2.3 Channels by Tenidap Suppresses Epileptiform Burst Discharges in Cultured Hippocampal Neurons. Wu X et al., 2019, CNS Neurol Disord Drug Targets
    Read more